马拉维抗逆转录病毒治疗者的高癌症负担:观察性HIV队列与癌症登记记录链接研究
卡波西肉瘤年龄标化发病率最高(634.7/10万人年),其次为宫颈癌(36.6/10万人年);非艾滋病定义癌症仅占新发癌症的6%。结论认为马拉维ART使用者的癌症负担尚未反映高收入国家模式,卡波西肉瘤和宫颈癌筛查管理仍是重点。
要点
- 马拉维ART使用者中卡波西肉瘤发病率远高于其他癌种,宫颈癌次之。
- 非艾滋病定义癌症占新发癌症比例低(6%),与高收入国家模式不同。
- HIV诊所应优先整合卡波西肉瘤和宫颈癌的筛查与管理。
核心结论
- 在历史ART指南下,马拉维ART使用者的非艾滋病定义癌症发病率低,被高卡波西肉瘤和宫颈癌负担所掩盖。
- 马拉维ART使用者的癌症负担尚未反映高收入国家的模式。
研究设计与样本
- 采用概率算法将马拉维最大两个HIV队列(2000-2010年)的ART电子病历与人群癌症登记进行记录链接。
主要发现
- 卡波西肉瘤年龄标化发病率最高,为634.7/10万人年(95%CI未报告),宫颈癌为36.6/10万人年。
- 卡波西肉瘤发病率在ART启动后4-24个月的早期时段最高。
- 非艾滋病定义癌症占新发癌症的6%。
- 60%的患者在WHO分期3或4期启动ART,12%在ART启动时已有现患恶性肿瘤。
关键数值与推荐
- 卡波西肉瘤年龄标化发病率为634.7/10万人年,宫颈癌为36.6/10万人年。
- 非艾滋病定义癌症占新发癌症的6%。
临床怎么用
- 在马拉维当前背景下,HIV诊所应整合癌症筛查与管理,尤其针对卡波西肉瘤和宫颈癌。
局限性
- 研究基于历史ART指南(2000-2010年),结论外推至当前ART标准需谨慎。
- 数据来自观察性队列与登记链接,可能存在链接错误或漏报。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With antiretroviral therapy (ART), AIDS-defining cancer incidence has declined and non-AIDS-defining cancers (NADCs) are now more frequent among human immunodeficiency virus (HIV)-infected populations in high-income countries. In sub-Saharan Africa, limited epidemiological data describe cancer burden among ART users. METHODS: We used probabilistic algorithms to link cases from the population-based cancer registry with electronic medical records supporting ART delivery in Malawi's 2 largest HIV cohorts from 2000-2010. Age-adjusted cancer incidence rates (IRs) and 95% confidence intervals were estimated by cancer site, early vs late incidence periods (4-24 and >24 months after ART start), and World Health Organization (WHO) stage among naive ART initiators enrolled for at least 90 days. RESULTS: We identified 4346 cancers among 28 576 persons. Most people initiated ART at advanced WHO stages 3 or 4 (60%); 12% of patients had prevalent malignancies at ART initiation, which were predominantly AIDS-defining eligibility criteria for initiating ART. Kaposi sarcoma (KS) had the highest IR (634.7 per 100 000 person-years) followed by cervical cancer (36.6). KS incidence was highest during the early period 4-24 months after ART initiation. NADCs accounted for 6% of new cancers. CONCLUSIONS: Under historical ART guidelines, NADCs were observed at low rates and were eclipsed by high KS and cervical cancer burden. Cancer burden among Malawian ART users does not yet mirror that in high-income countries. Integrated cancer screening and management in HIV clinics, especially for KS and cervical cancer, remain important priorities in the current Malawi context.
引用
- Horner MJ, Chasimpha S, Spoerri A, et al. High Cancer Burden Among Antiretroviral Therapy Users in Malawi: A Record Linkage Study of Observational Human Immunodeficiency Virus Cohorts and Cancer Registry Data. Clin Infect Dis. 2019. PMID: 30452634. doi:10.1093/cid/ciy960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。